ZANANDREA, LAURA
 Distribuzione geografica
Continente #
EU - Europa 316
AS - Asia 186
NA - Nord America 160
SA - Sud America 29
AF - Africa 9
Totale 700
Nazione #
RU - Federazione Russa 203
US - Stati Uniti d'America 149
CN - Cina 62
SG - Singapore 62
IT - Italia 55
BR - Brasile 24
HK - Hong Kong 20
VN - Vietnam 20
DE - Germania 15
IN - India 8
CA - Canada 7
FI - Finlandia 7
FR - Francia 7
GB - Regno Unito 7
ES - Italia 4
MX - Messico 4
NL - Olanda 4
PL - Polonia 4
ZA - Sudafrica 4
SE - Svezia 3
ZW - Zimbabwe 3
AR - Argentina 2
ID - Indonesia 2
IE - Irlanda 2
JP - Giappone 2
PK - Pakistan 2
TR - Turchia 2
AT - Austria 1
BD - Bangladesh 1
BE - Belgio 1
CH - Svizzera 1
EC - Ecuador 1
GA - Gabon 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
PY - Paraguay 1
UA - Ucraina 1
VE - Venezuela 1
Totale 700
Città #
Singapore 38
Moscow 33
Ashburn 24
Dallas 19
Hong Kong 19
New York 12
Beijing 11
Milan 11
Shanghai 9
Munich 8
San Jose 8
Council Bluffs 7
Lauterbourg 7
Orem 7
Hefei 6
Ho Chi Minh City 6
São Paulo 6
Denver 5
Poplar 5
Rho 5
Chennai 4
Los Angeles 4
Rome 4
Turku 4
Warsaw 4
Boardman 3
Guangzhou 3
Hanoi 3
Harare 3
Latina 3
Mexico City 3
Toronto 3
Amsterdam 2
Atlanta 2
Barcelona 2
Biên Hòa 2
Brooklyn 2
Cape Town 2
Dublin 2
Falkenstein 2
Florence 2
Hagen 2
Johannesburg 2
Lappeenranta 2
Montreal 2
Naples 2
Nuremberg 2
Pescara 2
Pune 2
Raleigh 2
San Cipriano d'Aversa 2
Santa Clara 2
Siano 2
Tianjin 2
Tokyo 2
Ankara 1
Araure 1
Asunción 1
Baie-D'Urfé 1
Bologna 1
Brasília 1
Brussels 1
Camden 1
Campinas 1
Cao Lanh 1
Chicago 1
Cormano 1
Da Nang 1
Dalian 1
Dhaka 1
Go Vap 1
Helsinki 1
Houston 1
Hải Dương 1
Itajaí 1
Jacareí 1
Jequié 1
Joinville 1
Karawang 1
Kathmandu 1
Kremenchug 1
Lagos 1
Lahore 1
Lakewood 1
Libreville 1
London 1
Manaus 1
Manchester 1
Manila 1
Medford 1
Memphis 1
Mumbai 1
Muniz Freire 1
Nanjing 1
New Delhi 1
New Lenox 1
Nova Lima 1
Ottawa 1
Palmares 1
Pavlodar 1
Totale 378
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 116
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 98
Vestibular Migraine Therapy: Update and Recent Literature Review 98
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 97
Crossing the border between epileptic and vascular pathology: a report of CACNA1A-related treatment-resistant hemiplegic migraine 90
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 80
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 61
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 52
Biomarkers of treatment response 35
Totale 727
Categoria #
all - tutte 2.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20237 0 0 1 0 2 0 1 1 0 0 2 0
2023/202443 3 2 3 4 5 6 2 11 0 1 1 5
2024/202599 7 0 6 5 9 10 7 10 7 6 22 10
2025/2026578 31 23 33 82 60 37 31 68 187 26 0 0
Totale 727